Actym Raises $59.5M In Series A funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Christopher Thanos News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Christopher Thanos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Christopher Thanos Today - Breaking & Trending Today
Actym Therapeutics Announces Significant Expansion of Senior Leadership
/PRNewswire/ -- Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory...
Source: prnewswire.com
Actym Therapeutics Announces Significant Expansion of Senior Leadership
/PRNewswire/ -- Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory...
Source: prnewswire.com
Actym Therapeutics Announces Significant Expansion of Senior Leadership
BERKELEY, Calif., May 12, 2022 /PRNewswire/ -- Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic pl...
Source: businessinsider.com
Actym Therapeutics and Wacker Biotech Sign Biomanufacturing Contract
Wacker Biotech will begin GMP production of Phase I clinical material of Actym’s therapeutic candidate at its site in Amsterdam using its LIBATEC® technology. Both companies have already been working on technology transfer and initiation of scale-up production of ACTM-838, which is Actym’s lead clinical development candidate for solid tumor therapy and is on the company's immunotherapy platform called STACT.
Source: genengnews.com